Physician profile
David Shusterman
NPI 1215138342
$10,317.85
in general payments reported to CMS, 2019-2025
49 companies · $905 in 2025
The $905 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $915 · 2020: $173 · 2021: $597 · 2022: $5,832 · 2023: $771 · 2024: $1,125 · 2025: $905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,701 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,701.04 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $4,700.91 | 2021-2022 | |
| Astellas Pharma US INC | $697.11 | 2019-2025 | Veozah, Xtandi, Myrbetriq |
| Boston Scientific Corporation | $479.81 | 2019-2025 | Spaceoar Vue System - 10ml, Varithena Administration Pack |
| Terumo Medical Corporation | $313.42 | 2022 | |
| Teleflex LLC | $297.02 | 2021 | |
| Mayne Pharma Commercial LLC | $257.57 | 2021-2025 | |
| Evofem Biosciences, INC. | $247.71 | 2022-2025 | Phexxi, Phexx, Solosec |
| Abbvie INC. | $238.80 | 2022-2025 | Botox |
| Urogen Pharma, INC. | $195.22 | 2025 | |
| Myovant Sciences INC. | $191.98 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $183.74 | 2023-2024 | Gemtesa, Myfembree |
| Janssen Biotech, INC. | $182.41 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Angiodynamics, INC. | $173.99 | 2024 | Nanoknife |
| Endo USA, INC. | $168.98 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $159.67 | 2019-2023 | Aveed, Xiaflex |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $154.62 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $122.24 | 2019 | |
| Curonix LLC | $117.77 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Myriad Genetic Laboratories, INC. | $107.56 | 2022-2025 | Prolaris |
| Nevro Corp. | $107.30 | 2022-2024 | Senza |
| Coloplast Corp | $100.93 | 2019-2023 | Speedicath |
| Daiichi Sankyo INC. | $98.11 | 2021-2022 | |
| Allergan, INC. | $83.48 | 2019-2021 | |
| Agile Therapeutics, INC. | $81.38 | 2021-2024 | Twirla |
| Hologic Sales and Service, LLC | $79.85 | 2020-2024 | Aptima |
| Millicent US INC | $77.04 | 2025 | Femlyv |
| Olympus America INC. | $70.09 | 2023-2025 | Itind System |
| Dentsply Ih Ab | $67.90 | 2023-2024 | Lofric, Lofric |
| Verity Pharmaceuticals INC. | $63.76 | 2025 | Tlando, Trelstar |
| Tolmar, INC. | $47.93 | 2024 | |
| Progenics Pharmaceuticals, INC. | $44.43 | 2021-2022 | |
| Dentsply Ih INC. | $37.19 | 2019-2020 | |
| 180 Medical, INC. | $30.64 | 2022 | |
| Novo Nordisk INC | $28.27 | 2025 | Rivfloza |
| Civco Medical Instruments | $28.09 | 2025 | |
| Phathom Pharmaceuticals, INC. | $26.79 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $25.32 | 2025 | |
| Tempus Ai, INC | $24.55 | 2024 | |
| Organon LLC | $23.37 | 2024 | |
| Therapeuticsmd, INC. | $22.59 | 2022 | |
| Exact Sciences Corporation | $21.22 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $20.42 | 2025 | Zepbound |
| Laborie Medical Technologies Corp. | $20.26 | 2024 | Urgent Pc Neuromodulation System |
| Blue Earth Diagnostics | $18.90 | 2019 | |
| Abc Home Medical Supply, INC. | $15.85 | 2024 | |
| Hollister Incorporated | $15.85 | 2024 | Vapro, Vapro Plus Pocket, Infyna Chic |
| Renovia INC | $15.80 | 2019 | |
| Antares Pharma, INC. | $15.21 | 2022 | |
| Aytu Biopharma, INC. | $14.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shusterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.